Friday, May 22, 2020 10:26:58 AM
Yarbrough was the CEO of Cision when it was bought for billions
Mathias (25% shareholder, founding investor in CCA, LLC in 2013) is listed as a retired director of The Carlyl group and consultant to the Carlyl Group. He is also a director of the UPenn/UPennMed Trust that controls by estimates about 20,000 patents and patent applications.
So you combine those 2, with Larry Kubin of Donnelly financials (The new MILVD website, NDTPharma.com is listed as registered to Larry Kubin) that Mathias said publicly is a great place to get $50 to $100 Mil dollar funding deals, and you have all the signs of an historic biotech launch underway.
All of my posts are strictly opinions and should not be considered to be facts, or investment advise. They are for entertainment purposes only.
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM